Patent Assignment
Reel/Frame 020035/0827
Merger
Recorded: 2007-10-31
Pages: 10
Assignor
ALKERMES CONTROLLED THERAPEUTICS, II
Executed: 2006-07-26
Assignee
ALKERMES, INC.
88 SIDNEY STREET, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Properties
(17)
Polymorphic Forms of Naltrexone
Methods for administering active agents to CYP 2D6 sensitive patients
Application:
10/635,233 →
Publication:
US US20050032781A1
Methods for administering active agents to CYP3A4 sensitive patients
Application:
10/635,234 →
Publication:
US US20050031713A1
Aripiprazole, olanzapine and haloperidol pamoate salts
Application:
11/252,862 →
Publication:
US US20060040922A1
Methods for administering aripiprazole
Application:
10/635,221 →
Publication:
US US20050032811A1
Methods for treating alcoholism
Application:
60/554,658 →
Methods for treating alcoholism
Application:
11/082,420 →
Publication:
US US20050245461A1
Methods for treating alcoholism
Application:
60/554,785 →
Methods for treating alcoholism
Application:
60/562,356 →
Methods for treating alcoholism
Application:
11/082,534 →
Publication:
US US20050245541A1
Naltrexone long acting formulations and methods of use
Application:
60/564,542 →
Naltrexone Long Acting Formulations and Methods of Use
Methods and compositions for the treatment of brain reward system disorders by combination therapy
Application:
60/733,050 →
Methods of treating alcoholism and alcohol related disorders using combination drug therapy and swellable polymers
Application:
60/763,972 →
Polymorphic forms of naltrexone
Application:
60/475,863 →
Polymorphic Forms of Naltrexone
Aripiprazole, Olanzapine and Haloperidol Pamoate Salts
Related Assignments
(11)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 7, 2004
From: BROWN, JOSIAH
To: ALKERMES CONTROLLED THERAPEUTICS, II
Reel/Frame 014857/0936 →
Patent Security Agreement (First Lien)
Sep 29, 2011
From: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 026994/0186 →
Patent Security Agreement (Second Lien)
Sep 29, 2011
From: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 026994/0245 →
Release by Secured Party (Second Lien)
Oct 12, 2012
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
Reel/Frame 029116/0379 →
Termination and Release of Security Interest in Patents (First Lien)
Feb 4, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 032161/0475 →
Assignment of Assignor's Interest
May 23, 2014
From: ALKERMES, INC.
To: OTSUKA PHARMACEUTICAL CO., LTD.
Reel/Frame 032959/0432 →
Assignment of Assignor's Interest
Oct 16, 2015
From: ALKERMES, INC.
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 036809/0447 →
Release of Patent Security Agreement (First Lien)
Dec 24, 2024
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 069771/0548 →
Security Interest
Oct 23, 2025
From: ALKERMES PHARMA IRELAND LIMITED
To: JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT
Reel/Frame 073213/0302 →
Security Interest
Feb 13, 2026
From: ALKERMES PHARMA IRELAND LIMITED
To: JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT
Reel/Frame 074858/0405 →
Release of Security Interest in Patents Previously Recorded at Reel/Frame (073213/0302)
Feb 13, 2026
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 074858/0429 →